Desiree Granados Quick Summary: Tirzepatide and semaglutide both support weight loss through incretin pathways, with tirzepatide targeting both GIP and GLP-1 receptors for potentially greater weight reduction in clinical studies, while semaglutide focuses on GLP-1 with wide usage and well-documented metabolic benefits
(3) Raun K, Hansen BS, Johansen NL, Thgersen H, Madsen K, Ankersen M, Andersen PH
Grab your copy and start your journey to better gut health today
The team may review your weight loss history, lifestyle habits, current medications, recovery needs, inflammation concerns, and overall wellness goals to determine whether peptide therapy is appropriate for you
Use our Photo Consultation Planner to explore Botox, filler, skin tightening, laser, facial, and rejuvenation options based on your concerns